Confirmatory Efficacy of the Building a Strong Identity and Coping Skills Program

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age11+
SponsorPenn State University

About this trial

The goal of this clinical trial is to the efficacy of the Building a Strong Identity and Coping Skills intervention within a sample of low-income and minoritized youth aged 11-14 who are seeking mental health treatment and have been placed on a waitlist to receive services.

The aims of this study are to: (1) confirm the efficacy of BaSICS by replicating previous findings, (2) Examine the changes of coping mechanisms and symptom change over the course of the BaSICS intervention, and (3) test models of physiologic stress reactivity and regulation to capture biological "risk" and recalibration.

Cohorts of 20 participants will randomly be enrolled in either the intervention (10) or control (10) groups. Participants enrolled in the intervention group will complete the BaSICS program and participants enrolled in the no intervention group will not be enrolled in the intervention program. The BaSICS program is designed to help treat anxiety, depression, and post-traumatic stress symptoms and disorders and have direct effects on physiologic stress response systems (hypothalamic-pituitary-adrenal (HPA) axis). Researchers will compare the intervention and no intervention groups to see if there is a difference in the reduction of markers for anxiety, depression, and suicide scores, changes in coping mechanism, and HPA reactivity profiles

Eligibility criteria

Qualifiers

Children ages 11-14 at intake

Family income at or below 200% federal poverty level

Child speaks English

Parent speaks English or Spanish

Disqualifiers

Intellectual disability

Autism spectrum disorder

High suicidal risk (score of 17 or more on the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-Kid))

Severe depression (score of 19 or more on Patient health questionnaire (PHQ).

Trial design

Treatments tested in this trial

  • Building a Strong Identity and Coping Skills

Treatment groups

360 Participants
are divided into 2 treatment groups

Sponsors and collaborators